secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0000950170-24-026223
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics completes 1-for-44 reverse stock split effective March 5, 2024
--------------------------------------------------------------------------------

- Stockholders approved reverse split at Special Meeting on February 5, 2024; board set ratio on February 27.
- Certificate of Amendment filed with Delaware on March 4; effective at 5:01 p.m. ET on March 5.
- Every 44 outstanding shares combined into 1 share; no fractional shares issued.
- Split-adjusted trading on Nasdaq begins March 6; new CUSIP number 03835L 306.
- Proportionate adjustments made to stock options, RSUs, warrants, and equity plan reserves.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024026223/0000950170-24-026223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024026223/apvo-20240305.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-026223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer